Overview
Ahmed Abdalla is a Hematologist and an Oncologist in Mobile, Alabama. Dr. Abdalla is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Familial Colorectal Cancer, Agranulocytosis, Chronic Familial Neutropenia, and Neuroendocrine Tumor.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1660 Spring Hill Ave, Mobile, AL 36604
Additional Areas of Focus
Dr. Abdalla has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Usa Health - Mci Business Services LLC
Daniel Cameron is a Hematologist and an Oncologist in Fairhope, Alabama. Dr. Cameron is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Colorectal Cancer, Lung Cancer, and Bone Marrow Aspiration.
Singing River Health System
James Clarkson is an Oncologist and a Hematologist in Pascagoula, Mississippi. Dr. Clarkson is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Anal Cancer, Breast Cancer, Familial Colorectal Cancer, and Paget Disease of the Breast. Dr. Clarkson is currently accepting new patients.
Usa Health - Mci Business Services LLC
Omar Alkharabsheh is a Hematologist Oncology specialist and a Hematologist in Mobile, Alabama. Dr. Alkharabsheh is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM), Multiple Myeloma, Thrombocytopenia, and Anemia. Dr. Alkharabsheh is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AgranulocytosisDr. Abdalla isAdvanced. Learn about Agranulocytosis.
- Anal CancerDr. Abdalla isAdvanced. Learn about Anal Cancer.
- AnemiaDr. Abdalla isAdvanced. Learn about Anemia.
- Cholangiocarcinoma (Bile Duct Cancer)
- Chronic Familial NeutropeniaDr. Abdalla isAdvanced. Learn about Chronic Familial Neutropenia.
- Colorectal CancerDr. Abdalla isAdvanced. Learn about Colorectal Cancer.
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Abdalla isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Abdalla isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Abdalla isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Abdalla isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.